Kennes Hung is a postdoctoral fellow at the Department of Obstetrics and Gynaecology at the Chinese University of Hong Kong (CUHK). Her research focuses on endometriosis, women’s health, and the development of novel therapeutics derived from natural compounds such as ProEGCG. She has extensive expertise in translational medicine, drug development, and biomarker discovery. Kennes plays a key role in bridging academic research and industry innovation, advancing new treatments for menstrual pain and endometriosis toward clinical application. Her current research also integrates artificial intelligence and molecular omics for endometriosis drug development aimed at improving women’s quality of life and promoting innovation in women’s health therapeutics.